2025 Anthelmintic Drugs Market Outlook: Key Indicators Shaping Growth Through 2034

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Will the Anthelmintic Drugs Industry Market Size Be by 2025?
Over recent years, the market size for anthelmintic drugs has witnessed a robust expansion. It is projected to rise from $3.16 billion in 2024 to $3.34 billion in 2025, with a compound annual growth rate (CAGR) of 5.6%. This growth during the historical period is due to factors like the high occurrence of helminth infections, increased public health initiatives, a surge in pharmaceutical research and development, enhanced awareness and education, along with economic growth.

What's the Long-Term Growth Forecast for the Anthelmintic Drugs Market Size Through 2029?
The market size for anthelmintic drugs is projected to experience robust expansion in the upcoming years, anticipated to reach $4.11 billion in 2029, with a 5.3% compound annual growth rate (CAGR). This expected surge during the projected period is ascribed to the rising incidences of parasitic infections worldwide, amplified usage of anthelmintics in livestock and pets, rising awareness and health initiatives, as well as an increase in international travel. Notable trends for the predicted period encompass ascending demand for combination treatments, a heightened concentration on managing drug resistance, a surge in the endorsement of tailored medication, the broadening of telemedicine's role in monitoring treatments, escalating research into unexplored drug targets, and an accentuation on preventative health measures.

View the full report here:
https://www.thebusinessresearchcompany.com/report/anthelmintic-drugs-global-market-report

What Are the Key Growth Drivers Fueling the Anthelmintic Drugs Market Expansion?
The anticipated surge in the anthelmintic drugs market is anticipated due to the increasing incidence of parasitic infections. Such infections occur from organisms, like protozoa, worms, or ectoparasites, that host on or within another organism. Poor sanitation, contaminated food or water, close contact with people or animals infected, inadequate hygiene, and limited access to clean resources are the catalysts for parasitic infections. Anthelmintic drugs, which treat infections created by parasitic worms by effectively purging or killing these parasites from the body of their hosts, play a crucial role. These medications effectively impede the physiological functions of parasites, resulting in their expulsion or death. For example, the Centers for Disease Control and Prevention, a US-based national public health agency, reported in July 2023 that the number of cyclosporiasis cases in Florida, caused by a tiny parasite, had doubled, escalating from 254 in 2021 to 513 in 2022. Hence, the increasing incidence of parasitic infections is acting as a catalyst for the growth of the anthelmintic drugs market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19291&type=smp

What Are the Key Trends Driving Anthelmintic Drugs Market Growth?
Key players in the anthelmintic drugs market are centreing their efforts on the creation of innovative combination drugs, aimed at offering comprehensive protection from various parasites. These combined anthelmintic drugs incorporate two or more anthelmintic agents to bolster their effectiveness against parasitic infections in both humans and animals. By working together, these drugs widen the scope of activity, slow down the evolution of drug resistance, and challenge already existing resistance profiles amongst parasites. For example, Zoetis Inc., an American animal health company, secured US. Food and Drug Administration's approval for their new label indication, Simparica Trio, in January 2022. This approval permits the use of Simparica Trio as a preventative measure against infections triggered by Borrelia burgdorferi, which is known for causing Lyme disease in dogs. Simparica Trio blends three active ingredients - sarolaner, moxidectin, and pyrantel, offering comprehensive protection against conditions like fleas, ticks, heartworms, roundworms and hookworms.

How Is the Anthelmintic Drugs Market Segmented?
The anthelmintic drugsmarket covered in this report is segmented -

1) By Drug Class: Benzimidazoles, Macrocyclic lactones, Pyrazinoisoquinolones, Tetrahydropyrimidines, Other Drug Classes
2) By Route Of Administration: Oral, Injectable
3) By Infection Type: Nematode Infections, Cestode Infections, Trematode Infections, Mixed Infections
4) By Distribution Channel: Hospitals And Clinics, Retail Pharmacies, Online Pharmacies, Veterinary Clinics And Supply Stores
5) By Application: Human Anthelmintics, Veterinary Anthelmintics

Subsegments:
1) By Benzimidazoles: Albendazole, Mebendazole, Fenbendazole, Oxfendazole, Thiabendazole
2) By Macrocyclic Lactones: Ivermectin, Moxidectin, Doramectin, Eprinomectin, Milbemycin Oxime
3) By Pyrazinoisoquinolones: Praziquantel, Cysticide
4) By Tetrahydropyrimidines: Pyrantel Pamoate, Pyrantel Tartrate
5) By Other Drug Classes: Imidazothiazoles, Aminoacetonitrile Derivatives, Spiroindoles, Arsenicals

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=19291&type=smp

Which Companies Are Leading the Charge in Anthelmintic Drugs Market Innovation?
Major companies operating in the anthelmintic drugs market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Bayer AG, Sanofi S.A., Novartis AG, GlaxoSmithKline plc, Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries Limited, Zoetis Inc., Hetero Labs Limited, Sun Pharmaceutical Industries Ltd., Galderma S.A., Cipla Inc., Ferring Pharmaceuticals Inc., Amneal Pharmaceuticals, Inc., Zydus Lifesciences Limited, Glenmark Pharmaceuticals Ltd., Mankind Pharma Ltd., Reese Pharmaceutical Company

Which Regions Are Leading the Global Anthelmintic Drugs Market in Revenue?
North America was the largest region in the anthelmintic drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the anthelmintic drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19291

"This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work."

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.